These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4641666)

  • 1. Acute anemia with factor VIII therapy.
    King EG; Clarke ME; Buchanan DI
    Ann Intern Med; 1972 Aug; 77(2):323-4. PubMed ID: 4641666
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemolytic anemia due to anti-B in antihemophiliac factor concentrates.
    Ashenhurst JB; Langehennig PL; Seeler RA; Telfer MC
    J Pediatr; 1976 Feb; 88(2):257-8. PubMed ID: 1249687
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemolytic anemia caused by infusion of factor VIII concentrates--a case report of hemophilia A with intracranial hemorrhage].
    Fukazawa K; Okuyama T; Manabe H; Kanaya J
    Rinsho Ketsueki; 1983 Jul; 24(7):892-6. PubMed ID: 6415317
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemolytic anemia and F. VIII concentrate.
    Girelli G
    Eur J Haematol; 1989 Apr; 42(4):414. PubMed ID: 2498124
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemophiliac with hemolytic anemia resulting from factor VIII concentrate.
    Soni NS; Patel AR; Vohra RM; Shah PC
    Acta Haematol; 1977; 58(5):294-7. PubMed ID: 413305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of hemolytic anemia following treatment with cryobulin].
    Pluta A; Kniaź M; Kowalewski J
    Wiad Lek; 1980 Apr; 33(7):555-7. PubMed ID: 6771920
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe serogenic hemolytic anemia caused by anti-D fraction in factor VIII concentrate].
    Schricker KT; Schrenk KH
    Thromb Diath Haemorrh; 1972 Jul; 27(3):523-8. PubMed ID: 4197045
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquired hemolytic anemia and thrombocytopenia (Evans' syndrome) in hemophilia.
    Harris PJ; Kessler CM; Lessin LS
    N Engl J Med; 1983 Jul; 309(1):50. PubMed ID: 6406894
    [No Abstract]   [Full Text] [Related]  

  • 9. Purity of concentrates for substitution therapy: acceptable and undesirable contaminants--Madrid 1978.
    Scand J Haematol Suppl; 1980; 35():65-89. PubMed ID: 6770460
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemolysis caused by factor VIII concentrates.
    Orringer EP; Koury MJ; Blatt PM; Roberts HR
    Arch Intern Med; 1976 Sep; 136(9):1018-20. PubMed ID: 962445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hemophilia with factor VIII concentrates.
    Agarwal MB; Mehta BC
    Indian J Med Sci; 1980 Sep; 34(9):226-30. PubMed ID: 6782019
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant factor VIII in hemophilia.
    Cohen A; Butler R
    N Engl J Med; 1991 May; 324(21):1515-6. PubMed ID: 1902552
    [No Abstract]   [Full Text] [Related]  

  • 13. [Side-effects of factor VIII substitution in patients with hemophilia A (author's transl)].
    Tilsner V; Reuter H
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):553-7. PubMed ID: 6808385
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM; Hedner U; Holmberg L
    Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of porcine factor VIII in Japan.
    Yoshioka A; Shima M; Morichika S; Terada S; Fukui H
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):26-8. PubMed ID: 7939769
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor VIII products in haemophilia A: one size fits all?
    Mannucci PM; Garagiola I
    Thromb Haemost; 2015 May; 113(5):911-4. PubMed ID: 25854290
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction: replacement therapy for hemophilia: impact on the immune system.
    Aledort LM
    Semin Hematol; 1993 Oct; 30(4 Suppl 5):1. PubMed ID: 8266117
    [No Abstract]   [Full Text] [Related]  

  • 18. Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.
    Hay CR; Lozier JN; Lee CA; Lafan M; Tradati H; Santagostino E; Ciavarella N; Schiavoni M; Fukui H; Yoshioka A
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):20-5. PubMed ID: 7939768
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prophylaxis in hemophilia].
    Ortega F; Martin-Villar J; Navarro JL
    Sangre (Barc); 1970; 15(3):355-61. PubMed ID: 5486763
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hemophilia A with actor VIII concentrate in urological operations and injuries of the urinary tract].
    Brühl P; Weibbach L; Brackmann HH
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):401-4. PubMed ID: 804604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.